1.15
price up icon0.88%   0.01
after-market アフターアワーズ: 1.15
loading
前日終値:
$1.14
開ける:
$1.11
24時間の取引高:
55,243
Relative Volume:
0.20
時価総額:
$11.53M
収益:
$996.00K
当期純損益:
$-6.09M
株価収益率:
-2.1698
EPS:
-0.53
ネットキャッシュフロー:
$-9.76M
1週間 パフォーマンス:
+13.86%
1か月 パフォーマンス:
+26.07%
6か月 パフォーマンス:
-27.67%
1年 パフォーマンス:
-38.50%
1日の値動き範囲:
Value
$1.08
$1.1799
1週間の範囲:
Value
$0.97
$1.1799
52週間の値動き範囲:
Value
$0.70
$2.44

Therapeuticsmd Inc Stock (TXMD) Company Profile

Name
名前
Therapeuticsmd Inc
Name
セクター
Healthcare (1154)
Name
電話
561-961-1900
Name
住所
951 YAMATO ROAD, SUITE 220, BOCA RATON, FL
Name
職員
1
Name
Twitter
@TherapeuticsMD
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
TXMD's Discussions on Twitter

TXMD を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
TXMD
Therapeuticsmd Inc
1.15 11.53M 996.00K -6.09M -9.76M -0.53
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.47 65.50B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.03 46.99B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.18 45.96B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
14.87 17.04B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
291.38 12.77B 2.76B 1.11B 898.10M 22.77

Therapeuticsmd Inc Stock (TXMD) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2020-08-07 ダウングレード Jefferies Hold → Underperform
2020-05-19 ダウングレード JP Morgan Overweight → Neutral
2019-12-02 開始されました Guggenheim Buy
2019-10-17 開始されました H.C. Wainwright Buy
2019-04-30 再開されました Noble Capital Markets Outperform
2018-06-15 開始されました JP Morgan Overweight
2017-09-08 開始されました Morgan Stanley Equal-Weight
2017-07-11 アップグレード Oppenheimer Perform → Outperform
2017-05-09 ダウングレード Oppenheimer Outperform → Perform
2016-11-22 再開されました Jefferies Buy
2016-11-22 開始されました Oppenheimer Outperform
2016-11-07 再開されました Guggenheim Buy
2016-04-04 開始されました Goldman Buy
2015-12-08 繰り返されました Jefferies Buy
2015-12-08 繰り返されました Stifel Buy
2015-09-21 繰り返されました Jefferies Buy
2015-06-09 開始されました Guggenheim Buy
2014-07-08 開始されました FBR Capital Outperform
2014-04-17 繰り返されました Noble Financial Buy
2014-01-28 繰り返されました Noble Financial Buy
すべてを表示

Therapeuticsmd Inc (TXMD) 最新ニュース

pulisher
Apr 24, 2025

TherapeuticsMD Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 24, 2025
pulisher
Apr 23, 2025

TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Apr 23, 2025
pulisher
Apr 23, 2025

TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com - Defense World

Apr 23, 2025
pulisher
Apr 21, 2025

TherapeuticsMD Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 21, 2025
pulisher
Apr 20, 2025

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com - Defense World

Apr 20, 2025
pulisher
Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

TherapeuticsMD director Tommy Thompson acquires $325 in stock By Investing.com - Investing.com Canada

Apr 15, 2025
pulisher
Apr 15, 2025

TherapeuticsMD CEO Marlan Walker acquires $489 in common stock - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

TherapeuticsMD CEO Marlan Walker buys $489 in common stock - Investing.com

Apr 15, 2025
pulisher
Apr 12, 2025

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

INVESTOR ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025
pulisher
Apr 11, 2025

DEADLINE TODAY: Lundin Law PC Announces a Securities Class Action Lawsuit against TherapeuticsMD, Inc. and Reminds Investors with Losses to Contact the Firm - ACCESS Newswire

Apr 11, 2025
pulisher
Apr 10, 2025

Mayne Pharma Faces Legal Challenge from TherapeuticsMD - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock - Investing.com Australia

Apr 10, 2025
pulisher
Apr 10, 2025

TherapeuticsMD CEO Marlan Walker buys $1,994 in stock By Investing.com - Investing.com India

Apr 10, 2025
pulisher
Apr 09, 2025

TherapeuticsMD Inc. stock rises Wednesday, still underperforms market - MarketWatch

Apr 09, 2025
pulisher
Apr 09, 2025

TherapeuticsmdFiles Lawsuit Against Mayne Pharma For Breach Of Contract - marketscreener.com

Apr 09, 2025
pulisher
Apr 04, 2025

TherapeuticsMD Inc. stock underperforms Friday when compared to competitors - MarketWatch

Apr 04, 2025
pulisher
Apr 03, 2025

TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 03, 2025
pulisher
Apr 02, 2025

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

TherapeuticsMD Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 31, 2025
pulisher
Mar 29, 2025

TherapeuticsMD Full Year 2024 Earnings: US$0.20 loss per share (vs US$0.74 loss in FY 2023) - Yahoo Finance

Mar 29, 2025
pulisher
Mar 29, 2025

TherapeuticsMD Reports Improved Financial Performance - TipRanks

Mar 29, 2025
pulisher
Mar 27, 2025

DEADLINE MONDAY: Levi & Korsinsky, LLP Reminds Shareholders of a Class Action to Recover Losses Suffered by Investors in TherapeuticsMD, Inc. and a Lead Plaintiff Deadline of June 19, 2017 -- TXMD - ACCESS Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

TherapeuticsMD Inc. (TXMD) reports earnings - Quartz

Mar 27, 2025
pulisher
Mar 27, 2025

TherapeuticsMD Reports Reduced Losses and Revenue Growth - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

TherapeuticsMD Announces Full Year 2024 Financial Results - Business Wire

Mar 27, 2025

Therapeuticsmd Inc (TXMD) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$9.46
price up icon 0.00%
$27.84
price up icon 0.61%
$101.77
price down icon 1.80%
$8.13
price up icon 1.25%
$106.73
price up icon 0.92%
$291.38
price down icon 1.70%
大文字化:     |  ボリューム (24 時間):